Loading organizations...
Developing a unique ketamine formulation for pain disorders.
Bexson Biomedical has raised $4.8M across 1 funding round.
Bexson Biomedical has raised $4.8M in total across 1 funding round.
Bexson Biomedical has raised $4.8M in total across 1 funding round.
Bexson Biomedical's investors include Warren Wright.
Bexson Biomedical has raised $4.8M across 1 funding round. Most recently, it raised $4.8M Series A in February 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 3, 2021 | $4.8M Series A | Warren Wright |